Irritable Bowel Syndrome: Clinical Manifestations, Dietary Influences, and Management

• Published in: Healthcare (Basel) Vol. 5; no. 2; p. 21
• Main Authors: Ikechi, Ronald, Fischer, Bradford D, DeSipio, Joshua, Phadtare, Sangita
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 26.04.2017; MDPI
• Subjects: Diet; fructose; functional gastrointestinal disorder; high-fructose corn syrup (HFCS); Irritable bowel syndrome; irritable bowel syndrome (IBS); Review; functional gastrointestinal disorder; fructose; high-fructose corn syrup (HFCS); irritable bowel syndrome (IBS)
• ISSN: 2227-9032; 2227-9032
• DOI: 10.3390/healthcare5020021

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that is characterized by symptoms of chronic abdominal pain and altered bowel habits in the absence of an overtly identifiable cause. It is the most commonly diagnosed functional gastrointestinal disorder, accounting for about one third of gastroenterology visits. It generally presents as a complex of symptoms, including psychological dysfunction. Hypersensitivity to certain foods, especially foods that contain high amounts of fructose, plays a role in the pathophysiology of IBS. Elevated consumption of high-fructose corn syrup (HFCS) has been discussed in this aspect. The treatment options for IBS are challenging and varied. In addition to dietary restrictions for HFCS-induced IBS, such as low-FODMAP (Fermentable Oligosaccharides, Disaccharide, Monosaccharides, and Polyols) diets, existing drug therapies are administered based on the predominant symptoms and IBS subtype. Patients with IBS are likely to suffer from issues, such as anxiety, depression, and post-traumatic-stress disorder. Biopsychosocial factors particularly socioeconomic status, sex, and race should, thus, be considered for diagnostic evaluation of patients with IBS.